This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The information contained within the download document is designed for pharmaceutical executives, marketing managers, product managers, sales and marketing executives, medical representatives, software engineers, developers, businessdevelopment executives and any other individual involved in the direct-to-consumer pharmaceutical marketing industry.
Reps should not just be pushing product messages – they should be asking doctors what they need right now and how they can help.”. Veeva highlights in the whitepaper that marketing and sales functions need to work closely together to deliver the right messages aligned with doctors’ real needs. Achieving digital excellence.
Pharma hasn’t fully moved into the experiential content space and is stuck on brand-centric content, which is not as engaging as experiential content that can make one question how a product impacts their life and how it helps doctors treat their patients better, Kapoor reasons. ” About the interviewee.
In the coming year, there will be a renewed focus on healthcare providers needing to shift their business models to highlight the new need to make healthcare accessible and effective, regardless of geography, location, and mobility. A recent report highlighted that over 40% of US adults had delayed seeing a doctor during the pandemic.
Doctors are often unfamiliar with these conditions. Doctors are heavily reliant on the observations of parents or caregivers and are constrained by the ability of the patient to convey symptoms they are experiencing. To complicate matters further, CNS conditions are often very difficult to identify, characterise and treat.
After a few years, I decided I wanted to move into the commercial side of the business, so I completed an MBA and went on to hold various positions in Corporate BusinessDevelopment, Life Science and Healthcare. I have been general manager for Merck Healthcare UK & Ireland since 2020.
The company, which brings together a multidisciplinary team of clinical fertility experts and world-class biosensor and digital technology engineers, with experienced corporate and businessdevelopment executives, was established in 2015 as a spin-out from the University of Southampton.
Irena Seredina holds a Medical Doctor, honors diploma and a Master of Science degree in Health Economics. She began her career at S-Clinical as a businessdeveloper and progressed to be the Head of Operations. She is currently responsible for customer relationships and strategic business.
As we’ve seen over those five years, biosimilars are critical in continuing to provide doctors and patients choice in their care plans as well as continuing to decrease overall healthcare costs. Sean McGowan is responsible for leading strategy and businessdevelopment initiatives for the Biosimilar product category at AmeriSourceBergen.
“Jeff brings decades of relevant experience, including building platform-based companies, advancing first-in-class programs, executing financing strategies to drive near and long-term value growth, negotiating innovative businessdevelopment partnerships and strategic transactions, and cultivating collaborative, high-performance cultures.
In January 2022, Holmes was found guilty of multiple counts of fraud in a federal trial where it was revealed that she had misled investors, patients and doctors about the capabilities of her company’s blood testing technology. In February, Holmes’ defense requested that she remain out of prison when she first appealed her conviction.
As moderator Gareth Powell – businessdevelopment officer, patient engagement and clinical development service project lead at the NIHR – noted, the Institute has seen fantastic feedback from patients on the increased use of virtual engagement over the course of pandemic. We can’t just say ‘Here’s an app, fill it in.
“We can couple that with claims data and directly look at healthcare resource utilisation and see which doctors patients are visiting and if they are going to the emergency room or urgent care because of pain,” Sackman states. He oversees operations, including businessdevelopment, sales and marketing, and people.
Multi-Specialty Experience The three doctors specialize in different therapeutic areas. For more information about Velocity’s organization and clinical trial capabilities in Europe, contact Évelyne Mabouellet Newton , Head of BusinessDevelopment for Velocity Europe. Dreykluft and Zöller are internists and cardiologists.
Ties Kroezen, venture leader of Community Life Centers and businessdevelopment manager for Philips Africa, tells us about the challenges present within the African healthcare system, solutions the company developed to help patients and providers connect, and how pharma can assist with delivering better care to African residents.
Prior to joining Calliditas Therapeutics as CMO, he held roles at GlaxoSmithKline (GSK) and Takeda, focusing on clinical and businessdevelopment in rare diseases. I’ve had a great passion for drug development in rare diseases,” says Dr. Philipson, underscoring a commitment that would shape his career’s trajectory.
Cefepime/enmetazobactam will be a welcome addition to the tools that doctors have to help their patients, and we look forward to introducing this antibiotic to hospitals and achieving a win-win collaboration.”. Staatz BusinessDevelopment & Strategy acted as corporate finance and transaction adviser on the deal.
It really gave me a different look at the healthcare system than I had from my mom being a doctor and so when I went into remission and I got off a lot of the medications and I’ve been feeling really good now for a couple of decades don’t try and do the math.
It really gave me a different look at the healthcare system than I had from my mom being a doctor and so when I went into remission and I got off a lot of the medications and I’ve been feeling really good now for a couple of decades don’t try and do the math.
Longwood has a robust research department with 7 post doctorates conducting research in molecular biology, microbiology, genomics, cancer biology, and immunology and publishing over 75 publications in different scientific journals in the past 5 years. Link to her profile: [link]. Dr. Barber also serves on Kiromic’s Scientific Advisory Board.
Dr. Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading businessdevelopment in industry. In the beginning, I always thought I wanted to be a doctor, but then I felt it was very depressing, particularly at that time and in that particular field.
Pfizer’s Meridian subsidiary, the manufacturer of EpiPen and other auto-injector products, which had been reported within the results of the Upjohn Business (4) in the first three quarters of 2020 , is now included within the Hospital therapeutic area for all periods presented. Some amounts in this press release may not add due to rounding.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content